中原建業(09982.HK)集中簽約27個項目 涉總合約建築面積逾354萬平方米
中原建業(09982.HK)公布,於2023年1月10日,公司於河南省鄭州市舉行了集中簽約儀式暨合作夥伴答謝會。於會上,集團共計集中簽約達27個項目,預計總合約建築面積354.43萬平方米。
27個項目中框架協議項目24個,預計總合約建築面積330.34萬平方米。其中,政府代建項目6個,預計總合約建築面積152.48萬平方米,佔總簽約項目預計合約建築面積的43%;河南省外項目3個,預計總合約建築面積29.12萬平方米。其餘3個項目為正式代建協議項目,預計總合約建築面積24.09萬平方米,均為河南省內商業代建項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.